Equifax (EFX) Expected to Announce Earnings on Tuesday

Equifax (NYSE:EFX - Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, April 22nd. Analysts expect the company to announce earnings of $1.45 per share and revenue of $1.41 billion for the quarter. Equifax has set its FY 2025 guidance at 7.250-7.650 EPS and its Q1 2025 guidance at 1.330-1.430 EPS.Parties that are interested in registering for the company's conference call can do so using this link.

Equifax (NYSE:EFX - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The credit services provider reported $2.12 earnings per share for the quarter, meeting analysts' consensus estimates of $2.12. Equifax had a return on equity of 19.13% and a net margin of 10.63%. On average, analysts expect Equifax to post $8 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Equifax Trading Up 1.0 %

Shares of NYSE:EFX traded up $2.15 during trading on Friday, reaching $221.43. The stock had a trading volume of 1,458,636 shares, compared to its average volume of 962,400. Equifax has a 52 week low of $199.98 and a 52 week high of $309.63. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.88 and a current ratio of 0.75. The firm's fifty day moving average is $236.87 and its 200 day moving average is $255.15. The stock has a market cap of $27.63 billion, a price-to-earnings ratio of 45.85, a P/E/G ratio of 2.79 and a beta of 1.65.

Equifax Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 21st were given a dividend of $0.39 per share. The ex-dividend date was Friday, February 21st. This represents a $1.56 dividend on an annualized basis and a yield of 0.70%. Equifax's dividend payout ratio (DPR) is currently 32.30%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Needham & Company LLC cut their target price on Equifax from $325.00 to $300.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Bank of America began coverage on Equifax in a report on Thursday, April 10th. They set a "buy" rating and a $280.00 price target on the stock. Barclays reiterated an "equal weight" rating and issued a $260.00 price objective (down previously from $325.00) on shares of Equifax in a research note on Friday, April 4th. Royal Bank of Canada raised shares of Equifax from a "sector perform" rating to an "outperform" rating and set a $300.00 target price on the stock in a research note on Thursday, March 20th. Finally, Wells Fargo & Company decreased their price target on shares of Equifax from $313.00 to $284.00 and set an "overweight" rating for the company in a research note on Monday, April 14th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $292.31.

Institutional Trading of Equifax

An institutional investor recently raised its position in Equifax stock. Brighton Jones LLC boosted its position in Equifax Inc. (NYSE:EFX - Free Report) by 49.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 3,638 shares of the credit services provider's stock after purchasing an additional 1,200 shares during the period. Brighton Jones LLC's holdings in Equifax were worth $927,000 as of its most recent SEC filing. Institutional investors and hedge funds own 96.20% of the company's stock.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.